Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts
- 1 May 2000
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 31 (5) , 1094-1106
- https://doi.org/10.1053/he.2000.6126
Abstract
Activation of hepatic stellate cells (HSCs) is the key step in liver fibrogenesis. Increased transforming growth factor β (TGF-β) expression and extracellular matrix production in patients with hepatic fibrosis and experimental models of liver fibrogenesis support implication of TGF-β in the pathogenesis of this disease. However, a causative role for TGF-β during transdifferentiation of HSCs has not been delineated in molecular detail. Using a rat cell culture model of HSC transdifferentiation, we analyzed TGF-β signal transduction and identified changes between stellate cells and their transdifferentiated phenotype. Fully transdifferentiated myofibroblasts, opposed to HSCs, were not inhibited in proliferation activity on treatment with TGF-β1. Furthermore, stimulation of α2 (I) collagen and Smad7 messenger RNA (mRNA) expression by TGF-β1 was achieved in stellate cells but not in myofibroblasts. Northern and Western blot analyses indicated significant expression of TGF-β receptors I and II in both cell types. In contrast, [125I]-TGF-β1 receptor affinity labeling displayed strongly reduced types I, II, and III receptor presentation at the cell surface of myofibroblasts. Moreover, myofibroblasts did not display DNA-binding SMAD proteins in electrophoretic mobility shift assays with a CAGA box. These data indicate that stellate cells are responsive to TGF-β1 treatment and transduce a signal that may play an important role in liver fibrogenesis. Myofibroblasts display decreased availability of surface receptors for TGF-β, which could be based on autocrine stimulation. However, lack of activated SMAD complexes with DNA-binding activity and absence of α2 (I) collagen transcription inhibition by latency-associated peptide (LAP)/anti-TGF-β antibody raise the possibility of TGF-β signaling independent receptor down-regulation in myofibroblasts.Keywords
This publication has 62 references indexed in Scilit:
- Molecular regulation of hepatic fibrogenesisJournal of Hepatology, 1998
- The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1The Journal of cell biology, 1998
- Regulation of differentiation by TFG-βCurrent Opinion in Genetics & Development, 1996
- TGF-β receptors and actionsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
- The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms.Genes & Development, 1994
- Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblastsThe Journal of cell biology, 1993
- Book Review Ethical Problems in Dialysis and Transplantation (Developments in Nephrology. Vol. 33.) Edited by Carl M. Kjellstrand and John B. Dossetor. 235 pp., illustrated. Boston, Kluwer Academic, 1992. $108.50. 0-7923-1625-8New England Journal of Medicine, 1993
- The response of rat liver perisinusoidal lipocytes to polypeptide growth regulator changes with their transdifferentiation into myofibroblast-like cells in cultureJournal of Hepatology, 1993
- Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)Growth Factors, 1993
- Transforming growth factor-beta in disease: the dark side of tissue repair.Journal of Clinical Investigation, 1992